171 related articles for article (PubMed ID: 23302455)
1. [Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus:one year follow-up].
Chen YF; Yang F; Yang YL; Wu N; Zheng ZG; Li XL; Yang B; Wang L; Chen Y; Lian HL; Song B; Xue YJ; Cai HW; Dou KF; Chen Y
Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):879-82. PubMed ID: 23302455
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
[TBL] [Abstract][Full Text] [Related]
3. Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass.
Yan H; Tang L; Chen T; Kral JG; Jiang L; Li Y; Hu R; Cui J; Li S; Tian F
Obes Facts; 2013; 6(2):176-84. PubMed ID: 23594442
[TBL] [Abstract][Full Text] [Related]
4. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
5. Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.
Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Briatore L; Andraghetti G; Catalano M; Cordera R
Obes Surg; 2014 Jul; 24(7):1036-43. PubMed ID: 24647849
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
[TBL] [Abstract][Full Text] [Related]
7. Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m
Gong K; Li K; Zhang N; Zhu B; Du D; Zhang D; Zhang Z; Peng J
Surg Endosc; 2017 Mar; 31(3):1172-1179. PubMed ID: 27422245
[TBL] [Abstract][Full Text] [Related]
8. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).
Yi B; Jiang J; Zhu L; Li P; Im I; Zhu S
Surg Obes Relat Dis; 2015; 11(5):1061-8. PubMed ID: 25843397
[TBL] [Abstract][Full Text] [Related]
10. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the metabolic effects of LSG and LRYGB in Chinese diabetes patients with BMI<35 kg/m
Du X; Zhou HX; Zhang SQ; Tian HM; Zhou ZG; Cheng Z
Surg Obes Relat Dis; 2017 Feb; 13(2):189-197. PubMed ID: 27720418
[TBL] [Abstract][Full Text] [Related]
12. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents.
Inge TH; Miyano G; Bean J; Helmrath M; Courcoulas A; Harmon CM; Chen MK; Wilson K; Daniels SR; Garcia VF; Brandt ML; Dolan LM
Pediatrics; 2009 Jan; 123(1):214-22. PubMed ID: 19117885
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases.
Xiaosong W; Chongyu S; Xuqi S; Peiwu Y; Yongliang Z
Obes Surg; 2019 Apr; 29(4):1164-1168. PubMed ID: 30645722
[TBL] [Abstract][Full Text] [Related]
14. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.
Xiong SW; Zhang DY; Liu XM; Liu Z; Zhang FT
World J Gastroenterol; 2014 Dec; 20(48):18427-31. PubMed ID: 25561812
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity.
Murad AJ; Cohen RV; de Godoy EP; Scheibe CL; Campelo GP; Ramos AC; de Lima RC; Pinto LEV; Coelho D; Costa HBF; Pinto ÍMP; Pereira T; Teófilo FRS; Valadão JA
Obes Surg; 2018 Mar; 28(3):599-605. PubMed ID: 28933045
[TBL] [Abstract][Full Text] [Related]
17. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
18. Modified Roux-en-Y gastric bypass for type 2 diabetes mellitus in China.
Sun ZC; Yu WS; Na Y; Xu DM; Zheng FC; Xu JY; Sun CB; Xu HM
Hepatogastroenterology; 2013; 60(121):129-31. PubMed ID: 22829557
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.
Dogan K; Betzel B; Homan J; Aarts EO; Ploeger N; de Boer H; Aufenacker TJ; van Laarhoven CJ; Janssen IM; Berends FJ
Obes Surg; 2014 Nov; 24(11):1835-42. PubMed ID: 25027982
[TBL] [Abstract][Full Text] [Related]
20. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
